CD1A and head and neck neoplasm: Among MSGN, SC and LeCa displayed the highest median number of CD1a+ DCs; however, due to the recent WHO Classification update of head and neck tumors, some cases previously identified as adenocarcinomas or acinar cell carcinomas were reclassified as SC, making a direct comparison with our patients unfeasible.